VSTM
VSTM
NASDAQ · Biotechnology

Verastem Inc

$5.18
+0.25 (+5.07%)
As of Mar 25, 2:55 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +171.2% upside
Low Target $11.84
Average Target $14.05
High Target $17.49
Current Price $5.18
Current
$5.18
Target
$14.05
$11.84 $14.05 avg $17.49
Scenario Analysis
Bear Case
$11.84
128.6%
Low target
Base Case
$14.05
+171.2%
Avg target
Bull Case
$17.49
+237.6%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$11.25
-53.9% from high
52-Week Low
$4.01
+29.2% from low
Target vs 52W High
$14.05
+24.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%